DA32 Life Science Tech Acquisition Corp. (DALS) has 3 open-market insider trades by 3 insiders since 2021. The most active filer is Keith Crandell, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Keith Crandell | Dir10% Owner | — | 1 | $16.0M | 2023-07-28 |
| Section 32 Fund 3, LP | Dir10% Owner | — | 1 | $8.0M | 2021-07-30 |
| DA32 Sponsor LLC | 10% Owner | — | 1 | $6.5M | 2021-07-30 |
| Deerfield Management Company, L.P. (series C) via Keith Crandell | Dir10% Owner | — | 0 | — | 2021-07-30 |
| ARCH Venture Partners XI, L.P. via Keith Crandell | 10% Owner | — | 0 | — | 2021-07-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Keith Crandell | Director & 10% Owner | Buy | $16.0M | 2021-07-30 |
| Section 32 Fund 3, LP | Director & 10% Owner | Buy | $8.0M | 2021-07-30 |
| DA32 Sponsor LLC | 10% Owner | Buy | $6.5M | 2021-07-30 |
Companies that share insiders with DALS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.